Philips and Masimo Extend Patient Monitoring Partnership with Focus on AI and Wearables

Philips and Masimo have announced a renewal of their long-standing collaboration in patient monitoring, expanding their focus to include the development of next-generation vital sign readers and artificial intelligence-powered solutions. The multi-year strategic agreement aims to integrate advanced monitoring technologies and develop new tools to enhance patient care.

Enhanced Integration and Expanded Market Reach

Under the renewed partnership, Philips will accelerate the integration of Masimo's SET pulse oximetry technology into its multi-parameter patient monitors through 2026 and beyond. This integration extends to Masimo's continuous hemoglobin monitoring, brain function assessment, and carbon dioxide exhalation tracking technologies.

The collaboration will also see Philips equipping its bedside monitors with internal Masimo hardware to connect with Masimo's Radius PPG wireless, wearable sensors. Additionally, Philips plans to broaden the adoption of Masimo's technologies across new market segments and devices.

Julia Strandberg, Philips' business leader for connected care, emphasized the partnership's role in staying ahead of evolving clinical needs and market trends. "This partnership allows us to respond quickly to evolving clinical needs and market trends, integrating proven technologies into solutions that are easy to use, reliable, and scalable," she stated.

AI and Wearable Technology Focus

A key aspect of the renewed collaboration is the joint development and promotion of AI-powered solutions. The companies aim to leverage artificial intelligence to enhance patient monitoring capabilities and improve overall care delivery.

The agreement also includes plans to integrate Masimo's Radius PPG wearable sensor technology with Philips monitors and next-generation wearable multi-parameter devices. This move aligns with the growing trend of wearable health technology in patient care settings.

Katie Szyman, Masimo's CEO, expressed enthusiasm about the partnership's potential impact: "We are excited to continue to partner with Philips to bring Masimo's newest innovations in wearables and artificial intelligence to Philips' platforms. Expanding our strong, long-standing partnership with Philips allows us to build on our shared legacies of innovation and helps ensure that Masimo's best-in-class technologies reach even more patients."

Strategic Implications and Industry Context

This renewed partnership comes two months after Philips announced a similar collaboration with Medtronic, another major player in the patient monitoring space. The agreement with Masimo reaffirms Philips' commitment to supporting vendor-neutral interoperability across healthcare systems.

The collaboration between Philips and Masimo is expected to drive innovation in patient monitoring technologies, potentially leading to improved patient outcomes and more efficient healthcare delivery. As the healthcare industry continues to embrace digital transformation and AI-driven solutions, partnerships like this are likely to play a crucial role in shaping the future of patient care.